Page 5 - Read Online
P. 5
Hepatoma Research
CONTENTS
Topic: The Interplay between Direct-Acting Antivirals and Hepatocellular
Carcinoma in Chronic Hepatitis C
1 No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a
meta-analysis
Stephanie M. Rutledge, Hui Zheng, Darrick K. Li, Raymond T. Chung
Hepatoma Res 2019;5:31 http://dx.doi.org/10.20517/2394-5079.2019.19
2 Response rates to direct antiviral agents among hepatitis C virus infected patients who develop
hepatocellular carcinoma following direct antiviral agents treatment
Michela Emma Burlone, Stefano Fangazio, Alessandro Croce, Elisa Ceriani, Rachele Rapetti, Cristina
Rigamonti, Carlo Smirne, Stelvio Tonello, Paolo Ravanini, Rosalba Minisini, Mario Pirisi
Hepatoma Res 2020;6:3 http://dx.doi.org/10.20517/2394-5079.2019.37
3 The interplay between direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C
Sun Hong Yoo, Jung Hyun Kwon
Hepatoma Res 2020;6:9 http://dx.doi.org/10.20517/2394-5079.2019.49
4 Treatment efficacy for patients with chronic hepatitis C and preexisting hepatocellular carcinoma
by directly acting antivirals
Chia-Yen Dai, Chung-Feng Huang, Meng-Hsuan Hsieh, Ching-I Huang, Ming-Lun Yeh, Pei-Chien Tsai,
Ching-Chih Lin, Meng-Szu Lee, Jeng-Fu Yang, Po-Yao Hsu, Yu-Ju Wei, Cheng-Ting Hsu, Po-Cheng
Liang, Yi-Hung Lin, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
Hepatoma Res 2020;6:16 http://dx.doi.org/10.20517/2394-5079.2019.40
5 Hepatocellular carcinoma and hepatitis C virus infection in Latin America: epidemiology,
diagnosis and treatment
Marina Galicia-Moreno, Hugo Christian Monroy-Ramirez, Marina Campos-Valdez, Jaime Sanchez-
Meza, Laura Sanchez-Orozco, Juan Armendariz-Borunda
Hepatoma Res 2020;6:20 http://dx.doi.org/10.20517/2394-5079.2019.36
6 The impact of direct-acting antivirals on hepatitis C associated hepatocellular carcinoma
Tai-Ping Lee, David Bernstein
Hepatoma Res 2020;6:21 http://dx.doi.org/10.20517/2394-5079.2019.44
7 Direct-acting antivirals and risk of hepatocellular carcinoma: from genetic signature to metabolic
risk factors
Stefano Gitto, Erica Villa
Hepatoma Res 2020;6:22 http://dx.doi.org/10.20517/2394-5079.2019.50
